Clark founded the United Patients Alliance in June 2014. He suffers from MS and relies on cannabis to treat his symptoms. He describes what is likely to happen if his supply runs out.
Clark comments on cannabis classification and the government’s attitude toward the drug. He mentions Sativex, a cannabinoid medicine derived from the cannabis plant and manufactured by GW Pharmaceuticals, which is licensed by the government.
As Political Director of the UPA, Jonathan is currently lobbying MPs to support medical cannabis legalisation. He feels that as there is a lot more research now highlighting its medicinal benefits, the time is appropriate to campaign on the subject and push for its legalisation.
Jonathan describes a strain called Charlotte’s Web, which is now grown in Colorado, U.S. specifically for children with epilepsy and seizures. It was named after Charlotte Figi, a small 5-year old girl who suffers from Dravet’s Syndrome that brings on multiple seizures a day. She was taking cannabis oil that reduced her seizures drastically.
Jonathan compares the medicinal benefits of cannabis with the harmful effects of alcohol. He stresses that the UPA is confident about representing thousands of patients across the country on this issue.
This recreational user expresses serious concerns over cannabis legalisation and feels that the addictive effects of the drug makes it hard to stop after a point.
While many argue over the addictive effects of cannabis, this user describes the dopamine addiction. He emphasises that when cannabis consumption stops, it is accompanied by withdrawal symptoms, in his case, loss of memory and language fluency.
